North America Neurorehabilitation Devices Market Forecast to 2031 - Regional Analysis - by Product Type, Application, and End User

Description

List of Tables

The North America neurorehabilitation devices market was valued at US$ 1,512.12 million in 2023 and is expected to reach US$ 3,891.70 million by 2031; it is estimated to register a CAGR of 12.5% from 2023 to 2031.

Increasing Prevalence of Neurological Diseases Fuels North America Neurorehabilitation Devices Market

Patients suffering from neurological diseases such as stroke, Parkinson's disease, multiple sclerosis (MS), Alzheimer's disease, and cerebral palsy require neurorehabilitation devices to improve their motor skills, cognitive abilities, and overall quality of life.

Stroke is a leading cause of long-term disability and reduces mobility in half of stroke survivors aged 65 and older. As per the Global Stroke Fact Sheet 2022, every year, there are more than 12.2 million new strokes. One in four people over 25 are likely to have a stroke in their lifetime. The factsheet also stated that there are more than 101 million people currently living across the globe who have already experienced a stroke. The Centers for Disease Control and Prevention estimated that annually, more than 795,000 people in the US have a stroke.

Neurorehabilitation devices are widely used to improve memory and communication difficulties and reduce neuropsychiatric symptoms, thereby helping improve the quality of life of dementia patients. Per the World Health Organization fact sheet in 2023, globally, more than 55 million people have dementia, and approximately 10 million new cases are diagnosed every year.

As per the Parkinson's Foundation, in 2022, approximately one million people in the US had Parkinson's disease, and ~90,000 new cases are diagnosed every year. The number of patients who have Parkinson's disease is expected to rise to 1.2 million by 2030.

The increasing prevalence of neurological diseases worldwide creates a burden on healthcare systems, bolstering the demand for neurorehabilitation devices.

North America Neurorehabilitation Devices Market Overview

The North America neurorehabilitation devices Market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. The country accounts for the major market share owing to the surging prevalence of neurological disorders, followed by the surging technological advancement in the field of neurorehabilitation devices. A large portion of the US population suffers from neurological conditions such as multiple sclerosis, cerebral palsy, etc. According to the Birth Injury Justice Center, cerebral palsy is the most common physical childhood disability affecting 1 million people in the US. Moreover, an increasing number of neuro rehab centers equipped with advanced technology is also expected to support the market growth during the forecast period. For instance, in June 2024, Neurofenix launched a virtual clinic for home-based Neuro Rehab in Florida to help patients perform varied exercises aimed at improving motor skills and functional ability, all from the comfort of their homes. In addition, in October 2020, Neuro Rehab VR its XR Therapy System, a clinically validated and FDA-registered virtual reality (VR) therapy system for neurological rehabilitation and physical therapy treatment and assessment in clinical environments. Therefore, above mentioned factors are expected to boost the neurorehabilitation market growth in the coming years.

North America Neurorehabilitation Devices Market Revenue and Forecast to 2031 (US$ Million)

North America Neurorehabilitation Devices Market Segmentation

The North America neurorehabilitation devices market is categorized into product type, application, end user, and country.

By product type, the North America neurorehabilitation devices market is segmented into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the North America neurorehabilitation devices market share in 2023.

In terms of application, the North America neurorehabilitation devices market is segmented into stroke, traumatic brain injury, spinal cord injury, Parkinson's disease, cerebral palsy, and others. The stroke segment held the largest share of the North America neurorehabilitation devices market share in 2023.

By end user, the North America neurorehabilitation devices market is segmented into rehabilitation centers, hospitals & clinics, and home care. The hospitals & clinics segment held the largest share of the North America neurorehabilitation devices market share in 2023.

Based on country, the North America neurorehabilitation devices market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America neurorehabilitation devices Market in 2023.

Abbott Laboratories, BIONIK, BioXtreme Ltd, Blackrock Microsystems Inc, Ekso Bionics Holdings Inc, EMOTIV, Hocoma AG, Medtronic Plc, Renishaw Plc, and Tyromotion GmbH are some of the leading companies operating in the North America neurorehabilitation devices market.

Product Code: BMIRE00031348

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Neurorehabilitation Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Average Selling Price

5. North America Neurorehabilitation Devices Market - Key Market Dynamics

5.1 North America Neurorehabilitation Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Neurological Diseases
- 5.2.2 Growing Number of Clinical Studies on Neurorehabilitation Devices
5.3 Market Restraints
- 5.3.1 High Costs Associated with Neurorehabilitation Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Technological Advancements
5.6 Impact of Drivers and Restraints:

6. North America Neurorehabilitation Devices Market - Analysis

6.1 North America Neurorehabilitation Devices Market Revenue (US$ Million), 2021-2031
6.2 North America Neurorehabilitation Devices Market Forecast Analysis

7. North America Neurorehabilitation Devices Market Analysis - by Product Type

7.1 Neurorobotic System
- 7.1.1 Overview
- 7.1.2 Neurorobotic System: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Brain Computer Interface
- 7.2.1 Overview
- 7.2.2 Brain Computer Interface: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Non-invasive Stimulators
- 7.3.1 Overview
- 7.3.2 Non-invasive Stimulators: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Wearable Devices
- 7.4.1 Overview
- 7.4.2 Wearable Devices: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Neurorehabilitation Devices Market Analysis - by Application

8.1 Stroke
- 8.1.1 Overview
- 8.1.2 Stroke: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Traumatic Brain Injury
- 8.2.1 Overview
- 8.2.2 Traumatic Brain Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Spinal Cord Injury
- 8.3.1 Overview
- 8.3.2 Spinal Cord Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parkinson's Disease
- 8.4.1 Overview
- 8.4.2 Parkinson's Disease: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cerebral Palsy
- 8.5.1 Overview
- 8.5.2 Cerebral Palsy: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Neurorehabilitation Devices Market Analysis - by End User

9.1 Rehabilitation Centers
- 9.1.1 Overview
- 9.1.2 Rehabilitation Centers: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Home Care
- 9.3.1 Overview
- 9.3.2 Home Care: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Neurorehabilitation Devices Market - Country Analysis

10.1 North America
- 10.1.1 North America Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 North America Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 United States: North America Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.2.2 United States: North America Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.2.3 United States: North America Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.3 Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Canada: North America Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.3.2 Canada: North America Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.3.3 Canada: North America Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.4 Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Mexico: North America Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.4.2 Mexico: North America Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.4.3 Mexico: North America Neurorehabilitation Devices Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations

12. Company Profiles

12.1 Blackrock Microsystems Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Hocoma AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Medtronic Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Tyromotion GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Ekso Bionics Holdings Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BIONIK
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Abbott Laboratories
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Renishaw Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 EMOTIV
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 BioXtreme Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms